|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01541 IMMUNEONCO-B
Nominal 
3.400 +0.010 (+0.295%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (202,583) | (128,035) | (367,554) | (238,710) |
| Net Cash from / (used in) Investing Activities | -- | 9,730 | 37,946 | (294,845) | 49 |
| Net Cash from / (used in) Financing Activities | -- | 402,359 | 258,925 | 331,035 | 179,380 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 209,506 | 168,836 | (331,364) | (59,281) |
| Cash & Cash Equivalents at beginning of period | -- | 477,601 | 306,983 | 635,212 | 668,326 |
| Effect of Foreign Exchange Rate Changes | -- | (7,543) | 1,791 | 3,135 | 26,167 |
| Others | -- | 0 | (9) | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 679,564 | 477,601 | 306,983 | 635,212 |
| Remarks: | Real time quote last updated: 04/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -164,188 |
| %Change | 7.604% |
| EPS / (LPS) | RMB -0.380 |
| NBV Per Share (¥) | RMB 1.455 |